Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Albumin Excipient Market Valued at Present and by 2029?

The size of the albumin excipient market has experienced significant growth recently. The market, which was worth $4.85 billion in 2024, is projected to increase to $5.15 billion in 2025. This represents a compound annual growth rate (CAGR) of 6.1%. The market’s expansion during the historic period can be linked to factors such as the growth of the biopharmaceutical industry, a rise in the adoption of biologics, an increase in chronic diseases, advancements in clinical practices and drug innovation, as well as a greater emphasis on drug delivery.

Expectations are high for significant expansion in the albumin excipient market in the coming years, with predictions that the market size will reach $6.64 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during this forecast period is largely due to the sustained expansion of the biopharmaceutical industry, an expanding biologics pipeline, an ageing population, initiatives for global vaccination, and increased funding in drug development. The future trends predicted for this period include properties of biodegradability and biocompatibility, increased cooperation and partnerships in research, fulfillment of regulatory compliance and maintaining quality standards, usage in cell therapy and the introduction of customised and tailored solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10672&type=smp

#What Drivers Are Influencing Growth In The Albumin Excipient Market?

The escalating incidence of long-lasting illnesses is anticipated to drive future growth in the albumin excipient market. Chronic diseases are those that persist for over three months and often progressively worsen. Albumin, which functions as a fluid volume expander in the blood and is the most prevalent circulating protein in plasma, is often utilized as a multipurpose protein carrier for enhancing the pharmacokinetic profile of peptide and protein-based medications and directing them towards specific targets within the body. This comes into play in treating a variety of illnesses, such as cancer and diabetes. For example, in February 2024, as per the World Health Organization, a United Nations agency based in Switzerland, it was projected that new cases of cancer will surpass 35 million by 2050. This represents a 77% surge from the projected 20 million cases in 2022. Thus, the rising incidence of chronic diseases is fueling the expansion of the albumin excipient market.

What Are The Main Segments Identified In The Albumin Excipient Market Research?

The albumin excipient market covered in this report is segmented –

1) By Product: Human Serum Albumin, Recombinant Albumin

2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

Subsegments:

1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin

2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin

What Are The Leading Trends And Opportunities In The Albumin Excipient Sector?

Key businesses in the albumin excipient market are employing a strategic collaboration model to cater to vital biotechnology and pharmaceutical sectors. This model means that companies exploit each other’s strengths and assets for mutual gains and achievements. For example, in October 2023, ARTES Biotechnology GmbH, a biotech firm in Germany, forged a partnership with Basic Pharma, a pharmaceutical business in the Netherlands, to enhance the production of recombinant protein. Through this collaboration, they aim to expedite the production of pharmaceutical recombinant protein by streamlining supply chains and minimizing the time-to-market for new products.

Which Companies Play A Key Role In The Development Of The Albumin Excipient Market?

Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

What Are The Key Regional Developments Shaping The Albumin Excipient Market?

North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10672&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model